GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...

Chennai: The Government of Tamil Nadu has announced a major expansion of healthcare infrastructure aimed at strengthening ...

Australia: In a recent study published in Diabetes, Obesity and Metabolism, the researchers present an innovative device that ...